These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 37965281

  • 1. Synergetic Photodynamic-Photothermal-Chemotherapy Dual Targeting Nanoplatform Effective Against Breast Cancer in-Mice Model.
    Li N, Jiang X, Zhang W, Xiao W, Wu Z, Wang H, He F.
    Int J Nanomedicine; 2023; 18():6349-6365. PubMed ID: 37965281
    [Abstract] [Full Text] [Related]

  • 2. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q, Zhang Y, Zhang W, Shan X, Yuan Y, Zhang H, Hou L, Zhang Z.
    Acta Biomater; 2016 Jul 01; 38():129-42. PubMed ID: 27090593
    [Abstract] [Full Text] [Related]

  • 3. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W, Qian J, Hou G, Wang Y, Wang J, Sun T, Ji L, Suo A, Yao Y.
    Acta Biomater; 2019 Jan 01; 83():400-413. PubMed ID: 30465921
    [Abstract] [Full Text] [Related]

  • 4. Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer.
    Li Q, Sun L, Hou M, Chen Q, Yang R, Zhang L, Xu Z, Kang Y, Xue P.
    ACS Appl Mater Interfaces; 2019 Jan 09; 11(1):417-429. PubMed ID: 30537815
    [Abstract] [Full Text] [Related]

  • 5. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J, Liu Y, Chen Y, Ouyang D, Yang G, Yu T.
    Int J Nanomedicine; 2018 Jan 09; 13():5991-6007. PubMed ID: 30323587
    [Abstract] [Full Text] [Related]

  • 6. Hyaluronic acid-modified manganese dioxide-enveloped hollow copper sulfide nanoparticles as a multifunctional system for the co-delivery of chemotherapeutic drugs and photosensitizers for efficient synergistic antitumor treatments.
    Li X, Pan Y, Zhou J, Yi G, He C, Zhao Z, Zhang Y.
    J Colloid Interface Sci; 2022 Jan 09; 605():296-310. PubMed ID: 34329981
    [Abstract] [Full Text] [Related]

  • 7. Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy.
    Liang J, Jin X, Chen B, Hu J, Huang Q, Wan J, Hu Z, Wang B.
    Nanotechnology; 2020 May 08; 31(19):195103. PubMed ID: 31978912
    [Abstract] [Full Text] [Related]

  • 8. Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy.
    Cheng X, Li D, Lin A, Xu J, Wu L, Gu H, Huang Z, Liu J, Zhang Y, Yin X.
    Int J Nanomedicine; 2018 May 08; 13():3661-3677. PubMed ID: 29983561
    [Abstract] [Full Text] [Related]

  • 9. Dual-responsive molybdenum disulfide/copper sulfide-based delivery systems for enhanced chemo-photothermal therapy.
    Zhang X, Wu J, Williams GR, Yang Y, Niu S, Qian Q, Zhu LM.
    J Colloid Interface Sci; 2019 Mar 15; 539():433-441. PubMed ID: 30599399
    [Abstract] [Full Text] [Related]

  • 10. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W, Qian J, Hou G, Wang Y, Wang J, Sun T, Ji L, Suo A, Yao Y.
    Acta Biomater; 2018 Dec 15; 82():171-183. PubMed ID: 30336271
    [Abstract] [Full Text] [Related]

  • 11. Hyaluronic Acid-Functionalized Gold Nanorods with pH/NIR Dual-Responsive Drug Release for Synergetic Targeted Photothermal Chemotherapy of Breast Cancer.
    Xu W, Qian J, Hou G, Suo A, Wang Y, Wang J, Sun T, Yang M, Wan X, Yao Y.
    ACS Appl Mater Interfaces; 2017 Oct 25; 9(42):36533-36547. PubMed ID: 28975790
    [Abstract] [Full Text] [Related]

  • 12. Targeted Drug Delivery System Based on Copper Sulfide for Synergistic Near-Infrared Photothermal Therapy/Photodynamic Therapy/Chemotherapy of Triple Negative Breast Cancer.
    Lv H, Zhu Y, Xue J, Jia X, Chen J.
    Langmuir; 2022 Dec 20; 38(50):15766-15775. PubMed ID: 36508193
    [Abstract] [Full Text] [Related]

  • 13. Engineering of a dual-modal phototherapeutic nanoplatform for single NIR laser-triggered tumor therapy.
    Zhang M, Qin X, Xu W, Wang Y, Song Y, Garg S, Luan Y.
    J Colloid Interface Sci; 2021 Jul 15; 594():493-501. PubMed ID: 33774405
    [Abstract] [Full Text] [Related]

  • 14. A multifunctional nanoplatform based on MoS2-nanosheets for targeted drug delivery and chemo-photothermal therapy.
    Yang Y, Wu J, Bremner DH, Niu S, Li Y, Zhang X, Xie X, Zhu LM.
    Colloids Surf B Biointerfaces; 2020 Jan 01; 185():110585. PubMed ID: 31683203
    [Abstract] [Full Text] [Related]

  • 15. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S, Zhang X, Williams GR, Wu J, Gao F, Fu Z, Chen X, Lu S, Zhu LM.
    Acta Biomater; 2021 May 01; 126():408-420. PubMed ID: 33731303
    [Abstract] [Full Text] [Related]

  • 16. Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo/photothermal/photodynamic therapy.
    Dash BS, Lu YJ, Pejrprim P, Lan YH, Chen JP.
    Biomater Adv; 2022 May 01; 136():212764. PubMed ID: 35929292
    [Abstract] [Full Text] [Related]

  • 17. Versatile chondroitin sulfate-based nanoplatform for chemo-photodynamic therapy against triple-negative breast cancer.
    Yu J, Xu J, Jiang R, Yuan Q, Ding Y, Ren J, Jiang D, Wang Y, Wang L, Chen P, Zhang L.
    Int J Biol Macromol; 2024 Apr 01; 265(Pt 1):130709. PubMed ID: 38462120
    [Abstract] [Full Text] [Related]

  • 18. An RGD-modified hollow silica@Au core/shell nanoplatform for tumor combination therapy.
    Li X, Xing L, Hu Y, Xiong Z, Wang R, Xu X, Du L, Shen M, Shi X.
    Acta Biomater; 2017 Oct 15; 62():273-283. PubMed ID: 28823719
    [Abstract] [Full Text] [Related]

  • 19. Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy.
    Zhang Y, Huang F, Ren C, Yang L, Liu J, Cheng Z, Chu L, Liu J.
    ACS Appl Mater Interfaces; 2017 Apr 19; 9(15):13016-13028. PubMed ID: 28378992
    [Abstract] [Full Text] [Related]

  • 20. Transferrin-conjugated UiO-66 metal organic frameworks loaded with doxorubicin and indocyanine green: A multimodal nanoplatform for chemo-photothermal-photodynamic approach in cancer management.
    Soman S, Kulkarni S, John J, Vineeth P, Ahmad SF, George SD, Nandakumar K, Mutalik S.
    Int J Pharm; 2024 Nov 15; 665():124665. PubMed ID: 39236772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.